| Azacitidine and venetoclax in previously untreated acute myeloid leukemia CD DiNardo, BA Jonas, V Pullarkat, MJ Thirman, JS Garcia, AH Wei, ... New England Journal of Medicine 383 (7), 617-629, 2020 | 1917 | 2020 |
| Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN H Döhner, AH Wei, FR Appelbaum, C Craddock, CD DiNardo, H Dombret, ... Blood, The Journal of the American Society of Hematology 140 (12), 1345-1377, 2022 | 1332 | 2022 |
| Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION) HM Kantarjian, NP Shah, JE Cortes, M Baccarani, MB Agarwal, ... Blood, The Journal of the American Society of Hematology 119 (5), 1123-1129, 2012 | 801 | 2012 |
| Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3 J Li, J Wang, J Wang, Z Nawaz, JM Liu, J Qin, J Wong The EMBO journal 19 (16), 4342-4350, 2000 | 762 | 2000 |
| ETO, fusion partner in t (8; 21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex J Wang, T Hoshino, RL Redner, S Kajigaya, JM Liu Proceedings of the National Academy of Sciences 95 (18), 10860-10865, 1998 | 707 | 1998 |
| Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells J Wang, Y Saunthararajah, RL Redner, JM Liu Cancer research 59 (12), 2766-2769, 1999 | 287 | 1999 |
| Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia P Montesinos, C Recher, S Vives, E Zarzycka, J Wang, G Bertani, ... New England Journal of Medicine 386 (16), 1519-1531, 2022 | 284 | 2022 |
| Identification of functional cooperative mutations of SETD2 in human acute leukemia X Zhu, F He, H Zeng, S Ling, A Chen, Y Wang, X Yan, W Wei, Y Pang, ... Nature genetics 46 (3), 287-293, 2014 | 284 | 2014 |
| Chromatin remodeling and leukemia: new therapeutic paradigms RL Redner, J Wang, JM Liu Blood, The Journal of the American Society of Hematology 94 (2), 417-428, 1999 | 263 | 1999 |
| Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial HH Zhu, DP Wu, J Jin, JY Li, J Ma, JX Wang, H Jiang, SJ Chen, XJ Huang Journal of Clinical Oncology 31 (33), 4215-4221, 2013 | 190 | 2013 |
| Chronic myeloid leukemia in Asia WY Au, PB Caguioa, C Chuah, SC Hsu, S Jootar, DW Kim, IY Kweon, ... International journal of hematology 89, 14-23, 2009 | 160 | 2009 |
| Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial J Jin, JX Wang, FF Chen, DP Wu, J Hu, JF Zhou, JD Hu, JM Wang, JY Li, ... The lancet oncology 14 (7), 599-608, 2013 | 157 | 2013 |
| 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies Y Xu, Q Liu, M Zhong, Z Wang, Z Chen, Y Zhang, H Xing, Z Tian, K Tang, ... Journal of hematology & oncology 12, 1-13, 2019 | 145 | 2019 |
| Precision therapy for acute myeloid leukemia X Yang, J Wang Journal of hematology & oncology 11, 1-11, 2018 | 139 | 2018 |
| The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage M Futaki, T Igarashi, S Watanabe, S Kajigaya, A Tatsuguchi, J Wang, ... Carcinogenesis 23 (1), 67-72, 2002 | 137 | 2002 |
| Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription JD Wood, FC Nucifora Jr, K Duan, C Zhang, J Wang, Y Kim, G Schilling, ... The Journal of cell biology 150 (5), 939-948, 2000 | 136 | 2000 |
| The expression of iASPP in acute leukemias X Zhang, M Wang, C Zhou, S Chen, J Wang Leukemia research 29 (2), 179-183, 2005 | 132 | 2005 |
| Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind … HP Erba, P Montesinos, HJ Kim, E Patkowska, R Vrhovac, P Žák, ... The Lancet 401 (10388), 1571-1583, 2023 | 129 | 2023 |
| Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina J Wang, ZX Shen, G Saglio, J Jin, H Huang, Y Hu, X Du, J Li, F Meng, ... Blood, The Journal of the American Society of Hematology 125 (18), 2771-2778, 2015 | 129 | 2015 |
| Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells Y Wang, Y Xu, S Li, J Liu, Y Xing, H Xing, Z Tian, K Tang, Q Rao, M Wang, ... Journal of hematology & oncology 11, 1-12, 2018 | 97 | 2018 |
